Results 141 to 150 of about 6,942 (191)

The impact of intermittent preventive treatment in school aged children with dihydroartemisinin piperaquine and artesunate amodiaquine on IgG response against six blood stage Plasmodium falciparum antigens. [PDF]

PLoS One
Lyimo E, Makenga G, Turner L, Lavstsen T, Lusingu JPA, Van Geertruyden JP, Minja DTR, Wang CW, Baraka V.   +8 more
europepmc   +1 more source

Impact of Sulfadoxine-Pyrimethamine and Dihydroartemisinin-Piperaquine as Intermittent Preventive Treatment in Pregnancy on Stool Antimicrobial Resistance Gene Abundance. [PDF]

Am J Trop Med Hyg
Opoku KB, Tompkins K, Waltmann A, Ciccone EJ, Bartlelt L, Andermann T, Chinkhumba J, Mathanga DP, Gutman JR, Juliano JJ.   +9 more
europepmc   +1 more source

"If they take it without knowing, they will default…": perceptions of targeted information transfer to promote adherence to intermittent preventive treatment with dihydroartemisinin-piperaquine for the prevention of malaria in pregnancy in western Kenya. [PDF]

Malar J
Hoyt J, Barsosio HC, Odero IA, Omondi B, Achieng F, Kariuki S, Hill J, Webster J.   +7 more
europepmc   +1 more source

Evaluation of Dihydroartemisinin-Piperaquine Efficacy and Molecular Markers in Uncomplicated Falciparum Patients: A Study across Binh Phuoc and Dak Nong, Vietnam. [PDF]

Medicina (Kaunas)
Tran THT, Hien BTT, Dung NTL, Huong NT, Binh TT, Van Long N, Ton ND.   +6 more
europepmc   +1 more source

Population-specific variations in <i>KCNH2</i> predispose patients to delayed ventricular repolarization upon dihydroartemisinin-piperaquine therapy. [PDF]

Antimicrob Agents Chemother
Camara MD, Zhou Y, Dara A, Tékété MM, Nóbrega de Sousa T, Sissoko S, Dembélé L, Ouologuem N, Hamidou Togo A, Alhousseini ML, Fofana B, Sagara I, Djimde AA, Gil PJ, Lauschke VM.   +14 more
europepmc   +1 more source

Dihydroartemisinin-piperaquine effectiveness for seasonal malaria chemoprevention in settings with extended seasonal malaria transmission in Tanzania. [PDF]

Sci Rep
Mwaiswelo R, Ngasala B, Chaky F, Molteni F, Mohamed A, Lazaro S, Samwel B, Mmbando BP.   +7 more
europepmc   +1 more source

Efficacy of artemether-lumefantrine and dihydroartemisinin-piperaquine and prevalence of molecular markers of anti-malarial drug resistance in children in Togo in 2021. [PDF]

Malar J
Dorkenoo AM, Warsame M, Ataba E, Hemou M, Yakpa K, Sossou E, Mitigmsagou M, Teou CD, Caspar E, Ma L, Djadou KE, Atcha-Oubou T, Rasmussen C, Menard D.   +13 more
europepmc   +1 more source

Pharmacometric evaluation of amodiaquine-sulfadoxine-pyrimethamine and dihydroartemisinin-piperaquine seasonal malaria chemoprevention in northern Uganda

Bonnington C, Nuwa A, Theiss-Nyland K, Kajubi R, Kamya MR, Nankabirwa J, Ebong C, Rassi C, Nabakooza J, Opigo J, Salandindi D, Odongo M, Sararat C, Watson JA, Suwannasin K, Proux S, Koesukwiwat U, Tarning J, Imwong M, Tibenderana J, Nosten F, White N.   +21 more
europepmc   +1 more source

Risk factors for non-participation in ivermectin and dihydroartemisinin-piperaquine mass drug administration for malaria control in the MASSIV trial. [PDF]

Malar J
Kositz C, Vasileva H, Mohammed N, Achan J, Dabira ED, D'Alessandro U, Bradley J, Marks M.   +7 more
europepmc   +1 more source

Intermittent preventive treatment with sulphadoxine-pyrimethamine but not dihydroartemisinin-piperaquine modulates the relationship between inflammatory markers and adverse pregnancy outcomes in Malawi. [PDF]

PLOS Glob Public Health
Cheng K, Aitken EH, Hasang W, Meagher N, Price DJ, Madanitsa M, Mwapasa V, Phiri KS, Dodd J, Ter Kuile FO, Rogerson SJ.   +10 more
europepmc   +1 more source